Universe Pharmaceuticals INC has 10 Schedule 13D or 13G filings on record since 2026-01-07. 9 holders' latest filing reports 5% or more of class a ordinary shares. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Origin Force Intelligence Limited | 18.3% | 916,759 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Gang Lai | 13.58% | 87,967 | SCHEDULE 13D, 2026-05-21 | 2026-05-07 |
| Orbis BioCapital Limited | 9.98% | 499,926 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Whitmore Limited | 9.97% | 499,424 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Horizon Ridge Limited | 9.97% | 499,424 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Clever Way Global Limited | 9.96% | 498,922 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Meridian Prosperous Limited | 9.96% | 498,922 | SCHEDULE 13G, 2026-09-01 | 2026-07-30 |
| Star Voyage International Limited | 9.94% | 497,917 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| August Luck Global Limited | 9.29% | 465,258 | SCHEDULE 13G, 2026-09-01 | 2026-07-27 |
| Sabby Management, LLC | 4.9% | 28,111 | SCHEDULE 13G/A, 2026-01-07 | 2025-12-31 |
Purpose of Transaction (Item 4)
Gang Lai
Gang Lai serves as Chief Executive Officer and Chairman of the Board of Directors of the Issuer. In such capacities, Gang Lai may engage in communications with the Issuer's Board of Directors, members of management, other shareholders, financial and legal advisers, and other parties regarding the Issuer, including but not limited to the Issuer's operations, governance and control. In addition, in these capacities, he may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as set forth herein, Gang Lai does not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. He may, at any time and from time to time, review or reconsider his position and/or change his purpose and/or formulate plans or proposals with respect thereto. Gang Lai acquired the ordinary shares pursuant to the Equity Grant and intends to maintain his holding in the Issuer on a continuing basis. Nevertheless, he may acquire additional shares of the Issuer or sell or otherwise dispose of any or all of the shares that he beneficially owns.Item 4 of the SCHEDULE 13D filed 2026-05-21
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-07 | Sabby Management, LLC | 4.9% | SCHEDULE 13G/A |
| 2026-05-21 | Gang Lai | 13.58% | SCHEDULE 13D |
| 2026-09-01 | Whitmore Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Orbis BioCapital Limited | 9.98% | SCHEDULE 13G |
| 2026-09-01 | Clever Way Global Limited | 9.96% | SCHEDULE 13G |
| 2026-09-01 | Origin Force Intelligence Limited | 18.3% | SCHEDULE 13G |
| 2026-09-01 | Horizon Ridge Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Meridian Prosperous Limited | 9.96% | SCHEDULE 13G |
| 2026-09-01 | August Luck Global Limited | 9.29% | SCHEDULE 13G |
| 2026-09-01 | Star Voyage International Limited | 9.94% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for Universe Pharmaceuticals INC. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.